Target intelligence / Profile preview

Fungal cell membrane and cell wall synthesis enzymes

Molecular classification
Enzyme
01

Overview

Fungal cell membrane and cell wall synthesis enzymes are a diverse group of proteins essential for the structural integrity and survival of fungal pathogens (StatPearls: Antifungal Medications). The fungal cell wall is a rigid outer layer composed of chitin and glucans (primarily 1,3-beta-glucan), which are synthesized by enzymes like chitin synthase and 1,3-beta-glucan synthase to protect the cell from environmental and osmotic stress (NCBI: The Fungal Cell Wall). The cell membrane's fluidity and function depend on ergosterol, a fungal-specific sterol produced through a multi-step biosynthetic pathway involving enzymes such as squalene epoxidase and lanosterol 14-alpha-demethylase (CYP51) (PubMed: Ergosterol Biosynthesis). Antifungal drugs exploit these unique pathways to achieve selective toxicity; for instance, echinocandins target the cell wall, while azoles and allylamines target membrane sterol synthesis (NIH: Antifungal Agents). Disruption of these enzymes leads to compromised cell boundaries, resulting in lysis or growth arrest. These enzymes are primary targets in the treatment of a wide range of mycoses, from superficial infections to life-threatening systemic candidiasis and aspergillosis (Nature Reviews Microbiology: Antifungal Resistance).

Other names
Fungal cell wall and membrane biosynthetic enzymesErgosterol and glucan synthesis enzymesAntifungal enzyme targets
02

Mechanism of action

Inhibition of 1,3-beta-glucan synthase (echinocandins), inhibition of lanosterol 14-alpha-demethylase (azoles), inhibition of squalene epoxidase (allylamines), and inhibition of C-14 sterol reductase/C-8 sterol isomerase (morpholines) (StatPearls: Antifungal Medications; PubMed: Ergosterol Biosynthesis).

03

Biological functions

Cell wall organizationSterol biosynthetic processCell membrane maintenanceMetabolic process
04

Disease associations

Infection
05

Safety considerations

Hepatotoxicity (StatPearls: Azole Antifungals)Drug-drug interactions via Cytochrome P450 inhibition (PubMed: CYP450 and Azoles)QTc prolongationInfusion-related reactions (NIH: Antifungal Agents)Teratogenicity
06

Interacting drugs

Fluconazole

10 more in the full profile.

07

Biomarkers

(1,3)-beta-D-glucan (BDG) (PubMed: BDG as a biomarker)Galactomannan (PubMed: Galactomannan for Aspergillus)Therapeutic drug monitoring (TDM) levels (Nature Reviews Microbiology: Antifungal Resistance)

Beyond the preview

Go deeper on Fungal cell membrane and cell wall synthesis enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal cell membrane and cell wall synthesis enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call